학술논문
LuCAB: A phase I/II trial evaluating cabazitaxel in combination with [ 177 Lu]Lu-PSMA-617 in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC).
Document Type
Article
Author
Source
Journal of Clinical Oncology; 2/21/2023 Supplement, Vol. 41, pTPS278-TPS278, 1p
Subject
Language
ISSN
0732183X